We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+7.56%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$207B
AUM Growth
+$20.6B
Cap. Flow
+$7.99B
Cap. Flow %
3.86%
Top 10 Hldgs %
26.62%
Holding
9,816
New
1,347
Increased
3,278
Reduced
3,435
Closed
1,488

Sector Composition

Rank Sector Weight
1 Consumer Staples 2.31%
2 Technology 1.26%
3 Financials 1.12%
4 Healthcare 1.04%
5 Consumer Discretionary 0.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XXII
8101
22nd Century Group
XXII
$2.36M
0
FRTX
8102
CALL
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$49K ﹤0.01%
51
-5
-9% -$6.31K
MCEP
8103
CALL
DELISTED
Mid-Con Energy Partners, LP
MCEP
$49K ﹤0.01%
845
-5
-0.6% -$227
MCEP
8104
PUT
DELISTED
Mid-Con Energy Partners, LP
MCEP
$49K ﹤0.01%
850
+150
+21% +$6.81K
IPCI
8105
PUT
DELISTED
Intellipharmaceuticals International Inc.
IPCI
$49K ﹤0.01%
+2,290
New +$41.1K
NAK
8106
CALL
Northern Dynasty Minerals
NAK
$984M
$48K ﹤0.01%
+67,300
New +$45.5K
STNG icon
8107
Scorpio Tankers
STNG
$3.72B
$48K ﹤0.01%
1,027
-12,362
-92% -$594K
PHLT
8108
CALL
DELISTED
Performant Healthcare Inc
PHLT
$48K ﹤0.01%
+16,200
New +$35.7K
ATRS
8109
CALL
DELISTED
Antares Pharma, Inc.
ATRS
$48K ﹤0.01%
+28,700
New +$35.2K
CPSS icon
8110
Consumer Portfolio Services
CPSS
$200M
$47K ﹤0.01%
10,243
-8,129
-44% -$33K
GEVO icon
8111
CALL
Gevo
GEVO
$403M
$47K ﹤0.01%
243
-190
-44% -$41.4K
NAK
8112
Northern Dynasty Minerals
NAK
$984M
$47K ﹤0.01%
+66,714
New +$45.1K
SNOA icon
8113
Sonoma Pharmaceuticals
SNOA
$6.61M
$47K ﹤0.01%
+60
New +$45.1K
FRTX
8114
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$47K ﹤0.01%
+49
New +$61.8K
GPL
8115
DELISTED
Great Panther Mining Limited
GPL
$47K ﹤0.01%
3,467
-5,952
-63% -$83.1K
ECYT
8116
PUT
DELISTED
Endocyte, Inc. Common Stock
ECYT
$47K ﹤0.01%
+15,200
New +$47.4K
ACUR
8117
CALL
DELISTED
Acura Pharmaceuticals
ACUR
$47K ﹤0.01%
29,300
-2,500
-8% -$4.43K
MOBL
8118
DELISTED
MobileIron, Inc.
MOBL
$47K ﹤0.01%
+17,010
New +$52.6K
DRRX
8119
DELISTED
DURECT Corp
DRRX
$46K ﹤0.01%
3,254
-353
-10% -$5.79K
GPUS
8120
Hyperscale Data Inc
GPUS
$34.2M
0
GSS
8121
CALL
DELISTED
Golden Star Resources Ltd.
GSS
$46K ﹤0.01%
10,880
+2,240
+26% +$8.77K
AFMD
8122
PUT
DELISTED
Affimed
AFMD
$45K ﹤0.01%
+1,630
New +$45.7K
CNSY
8123
CALL
Cerenome
CNSY
$23.1M
0
NETI
8124
CALL
DELISTED
Eneti Inc.
NETI
$45K ﹤0.01%
+1,388
New +$43.2K
CYTO
8125
PUT
DELISTED
Altamira Therapeutics Ltd
CYTO
0

Similar funds

Jeff Yass's Q3 2016 Portfolio in Review

As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.

By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Apple, an estimated $762M trimmed.

  • Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
  • Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
  • Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
  • Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
  • Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
  • Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
  • Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.

Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.